From: The pathogenic mutations of APOA5 in Chinese patients with hyperlipidemic acute pancreatitis
HLAP group (n = 163) | BAP group (n = 30) | P value | |
---|---|---|---|
Age (years) | 39.71 ± 9.86 | 58.3 ± 15.95 | < 0.001*** |
Male, n (%) | 128(80.5%) | 11(68.8%) | 0.433 |
Hospital stay (days) | 10.47 ± 7.31 | 10.43 ± 4.64 | 0.561 |
BMI (kg/m2) | 27.76 ± 3.72 | 25.11 ± 4.32 | 0.001** |
WBC (× 10ꝰ /L) | 14.14 ± 4.18 | 11.69 ± 3.84 | 0.002** |
CRP (mg/L) | 185.08 ± 115.24 | 61.66 ± 64.39 | < 0.001*** |
BUN (mmol/L) | 5.76 ± 9.17 | 4.73 ± 1.84 | 0.950 |
Serum creatinine (μmol/L) | 70.04 ± 27.18 | 68.36 ± 13.34 | 0.551 |
Ca2+ (mmol/L) | 2.06 ± 0.23 | 2.09 ± 0.22 | 0.256 |
GLU (mmol/L) | 10.68 ± 5.20 | 7.38 ± 2.70 | 0.001** |
TG (mmol/L) | 18.00 ± 19.30 | 0.91 ± 0.34 | < 0.001*** |
TC (mmol/L) | 9.20 ± 5.27 | 4.02 ± 0.90 | < 0.001*** |
Diabetes mellitus, n (%) | 87(53%) | 4(13%) | < 0.001*** |
Hypertension, n (%) | 36(22%) | 12(40%) | 0.037* |
Fatty liver, n (%) | 138(85%) | 7(23%) | < 0.001*** |
ARDS, number, n (%) | 10(6%) | 2(7%) | 0.912 |
SAP number, n (%) | 10(6%) | 2(7%) | 0.912 |
MSAP & SAP number, n (%) | 83(50.9%) | 5(17%) | 0.001** |
CTSI > 4 score number, n (%) | 72(44.2%) | 5(16.7%) | 0.005** |
Recurrence, n (%) | 91(55.8%) | 7(23.3%) | 0.001** |
Repeated recurrence, n (%) | 61(37.4%) | 3(10.0%) | 0.003** |